Williams-Sonoma Beats Q4 Estimates But Stock Tumbles On Soft 2025 Outlook
WSM stock falls after reporting strong Q4 2024 results, with revenue up 8%, earnings per share surpassing estimates, and record operating margin. read more
Read More
Analysts See Upside For 95% Of S&P 500 Stocks: How Nvidia, Tesla Stack Up
The market downturn has investors questioning if it’s temporary or a prolonged bear market. An indicator suggests significant upside potential across the board, with stocks like Nvidia and Tesla ranking high. Analysts see potential gains for stocks like Caesars, Western Digital, United and Delta. read more
Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million
Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics’ BDTX-4933 for solid tumors for an upfront payment of $70 million and up to $710 million in milestone payments. read more
Fed Must Be ‘A Little Cautious’ On Rate Cuts, Warns BofA CEO
Fed should remain cautious about cutting rates due to solid consumer spending and 2% GDP growth projection, Bank of America CEO says. read more
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock’s unit is now Haleon’s largest shareholder with over 5%. read more
Zoom Communications Looks For AI Monetization, Expect Revenue To Accelerate In 2027: Analyst
Zoom unveils new capabilities at Enterprise Connect 2025. Analysts report positive outlook on position, customer churn. Latest Ratings for ZM Date Firm Action From To Mar 2022 Wolfe Research Downgrades Outperform Peer Perform Mar 2022 RBC Capital Maintains Outperform Mar 2022 Wells Fargo Maintains Equal-Weight View More Analyst Ratings for ZM View the Latest Analyst…